| 0 |
PSORIASIS |
50 |
| 1 |
DRUG INEFFECTIVE |
19 |
| 2 |
PRURITUS |
16 |
| 3 |
PRODUCT DOSE OMISSION ISSUE |
15 |
| 4 |
HEADACHE |
14 |
| 5 |
NAUSEA |
12 |
| 6 |
DIARRHOEA |
11 |
| 7 |
APPLICATION SITE PAIN |
10 |
| 8 |
RASH |
10 |
| 9 |
SKIN BURNING SENSATION |
10 |
| 10 |
OFF LABEL USE |
9 |
| 11 |
SKIN EXFOLIATION |
9 |
| 12 |
APPLICATION SITE ERYTHEMA |
8 |
| 13 |
APPLICATION SITE IRRITATION |
8 |
| 14 |
ERYTHEMA |
8 |
| 15 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
8 |
| 16 |
PAIN |
8 |
| 17 |
PRODUCT USE IN UNAPPROVED INDICATION |
8 |
| 18 |
COVID-19 |
7 |
| 19 |
FATIGUE |
7 |
| 20 |
DERMATITIS ATOPIC |
6 |
| 21 |
DRY SKIN |
6 |
| 22 |
PERIPHERAL SWELLING |
6 |
| 23 |
SKIN IRRITATION |
6 |
| 24 |
THERAPY NON-RESPONDER |
6 |
| 25 |
VOMITING |
6 |
| 26 |
ARTHRALGIA |
5 |
| 27 |
BURNING SENSATION |
5 |
| 28 |
PNEUMONIA |
5 |
| 29 |
PSORIATIC ARTHROPATHY |
5 |
| 30 |
TREATMENT FAILURE |
5 |
| 31 |
ABDOMINAL PAIN UPPER |
4 |
| 32 |
APPLICATION SITE PRURITUS |
4 |
| 33 |
DIZZINESS |
4 |
| 34 |
JOINT SWELLING |
4 |
| 35 |
MATERNAL EXPOSURE DURING PREGNANCY |
4 |
| 36 |
SKIN ATROPHY |
4 |
| 37 |
SKIN DISCOLOURATION |
4 |
| 38 |
SKIN EROSION |
4 |
| 39 |
SLEEP DISORDER |
4 |
| 40 |
SQUAMOUS CELL CARCINOMA |
4 |
| 41 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
4 |
| 42 |
ABORTION SPONTANEOUS |
3 |
| 43 |
ACCIDENTAL EXPOSURE TO PRODUCT |
3 |
| 44 |
APPLICATION SITE RASH |
3 |
| 45 |
DECREASED APPETITE |
3 |
| 46 |
DEVICE DISLOCATION |
3 |
| 47 |
DRUG HYPERSENSITIVITY |
3 |
| 48 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
3 |
| 49 |
ECZEMA |
3 |
| 50 |
FEELING ABNORMAL |
3 |
| 51 |
GAIT DISTURBANCE |
3 |
| 52 |
ILLNESS |
3 |
| 53 |
INTENTIONAL PRODUCT USE ISSUE |
3 |
| 54 |
KNEE ARTHROPLASTY |
3 |
| 55 |
OSTEOMYELITIS |
3 |
| 56 |
PAIN OF SKIN |
3 |
| 57 |
PUSTULE |
3 |
| 58 |
RASH ERYTHEMATOUS |
3 |
| 59 |
SKIN INDURATION |
3 |
| 60 |
SWELLING |
3 |
| 61 |
SWELLING FACE |
3 |
| 62 |
THERAPEUTIC RESPONSE DECREASED |
3 |
| 63 |
ABDOMINAL DISCOMFORT |
2 |
| 64 |
ABDOMINAL PAIN |
2 |
| 65 |
ANKLE FRACTURE |
2 |
| 66 |
APPLICATION SITE EXFOLIATION |
2 |
| 67 |
BASAL CELL CARCINOMA |
2 |
| 68 |
BLOOD PRESSURE INCREASED |
2 |
| 69 |
BOWENOID PAPULOSIS |
2 |
| 70 |
BOWEN^S DISEASE |
2 |
| 71 |
CELLULITIS |
2 |
| 72 |
CHILLS |
2 |
| 73 |
CONDITION AGGRAVATED |
2 |
| 74 |
CONTRAINDICATED PRODUCT ADMINISTERED |
2 |
| 75 |
COUGH |
2 |
| 76 |
DENTAL IMPLANTATION |
2 |
| 77 |
DEPRESSION |
2 |
| 78 |
DERMATITIS CONTACT |
2 |
| 79 |
DISEASE RECURRENCE |
2 |
| 80 |
EXFOLIATIVE RASH |
2 |
| 81 |
FACIAL OPERATION |
2 |
| 82 |
GENITAL ERYTHEMA |
2 |
| 83 |
HAIR GROWTH ABNORMAL |
2 |
| 84 |
HYPERSENSITIVITY |
2 |
| 85 |
INFLUENZA |
2 |
| 86 |
INJECTION SITE HAEMORRHAGE |
2 |
| 87 |
INJECTION SITE PAIN |
2 |
| 88 |
INJECTION SITE REACTION |
2 |
| 89 |
KERATOACANTHOMA |
2 |
| 90 |
KIDNEY INFECTION |
2 |
| 91 |
LICHENOID KERATOSIS |
2 |
| 92 |
LIMB OPERATION |
2 |
| 93 |
LOCALISED INFECTION |
2 |
| 94 |
MAJOR DEPRESSION |
2 |
| 95 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
2 |
| 96 |
MENISCUS INJURY |
2 |
| 97 |
MIGRAINE |
2 |
| 98 |
MUSCULAR WEAKNESS |
2 |
| 99 |
MYALGIA |
2 |
| 100 |
PRODUCT DISTRIBUTION ISSUE |
2 |
| 101 |
PRODUCT PRESCRIBING ISSUE |
2 |
| 102 |
PYREXIA |
2 |
| 103 |
RASH PRURITIC |
2 |
| 104 |
SEBORRHOEA |
2 |
| 105 |
SEPSIS |
2 |
| 106 |
SINUSITIS |
2 |
| 107 |
SKIN ABRASION |
2 |
| 108 |
SKIN DISORDER |
2 |
| 109 |
SKIN HYPOPIGMENTATION |
2 |
| 110 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
2 |
| 111 |
THERAPEUTIC RESPONSE SHORTENED |
2 |
| 112 |
THERAPY INTERRUPTED |
2 |
| 113 |
THROAT IRRITATION |
2 |
| 114 |
UPPER RESPIRATORY TRACT INFECTION |
2 |
| 115 |
URTICARIA |
2 |
| 116 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
2 |
| 117 |
ACUTE CARDIAC EVENT |
1 |
| 118 |
ACUTE SINUSITIS |
1 |
| 119 |
ADENOMA BENIGN |
1 |
| 120 |
AGEUSIA |
1 |
| 121 |
AGGRESSION |
1 |
| 122 |
AGITATION |
1 |
| 123 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
| 124 |
ALLERGIC COUGH |
1 |
| 125 |
ALOPECIA |
1 |
| 126 |
AMNIOTIC FLUID INDEX DECREASED |
1 |
| 127 |
ANAL FISSURE |
1 |
| 128 |
ANAPHYLACTIC SHOCK |
1 |
| 129 |
ANGLE CLOSURE GLAUCOMA |
1 |
| 130 |
ANOSMIA |
1 |
| 131 |
ANXIETY |
1 |
| 132 |
APPLICATION SITE ATROPHY |
1 |
| 133 |
APPLICATION SITE BURN |
1 |
| 134 |
APPLICATION SITE DISCOLOURATION |
1 |
| 135 |
APPLICATION SITE HAEMORRHAGE |
1 |
| 136 |
APPLICATION SITE INFLAMMATION |
1 |
| 137 |
APPLICATION SITE LACERATION |
1 |
| 138 |
APPLICATION SITE SCAB |
1 |
| 139 |
APPLICATION SITE STREAKING |
1 |
| 140 |
ARTHROPATHY |
1 |
| 141 |
ASTHENIA |
1 |
| 142 |
ATRIAL FIBRILLATION |
1 |
| 143 |
BACK DISORDER |
1 |
| 144 |
BACK PAIN |
1 |
| 145 |
BLISTER |
1 |
| 146 |
BLISTER INFECTED |
1 |
| 147 |
BLOOD GLUCOSE FLUCTUATION |
1 |
| 148 |
BLOOD GLUCOSE INCREASED |
1 |
| 149 |
BLOOD IMMUNOGLOBULIN A DECREASED |
1 |
| 150 |
BLOOD IRON DECREASED |
1 |
| 151 |
BLOOD TESTOSTERONE DECREASED |
1 |
| 152 |
BODY HEIGHT DECREASED |
1 |
| 153 |
BONE LOSS |
1 |
| 154 |
BOWEL MOVEMENT IRREGULARITY |
1 |
| 155 |
BRAIN OPERATION |
1 |
| 156 |
BREAST CANCER |
1 |
| 157 |
BREAST CANCER FEMALE |
1 |
| 158 |
BREAST SWELLING |
1 |
| 159 |
CANDIDA INFECTION |
1 |
| 160 |
CATARACT |
1 |
| 161 |
CELLULITIS STAPHYLOCOCCAL |
1 |
| 162 |
CENTRAL SEROUS CHORIORETINOPATHY |
1 |
| 163 |
CHEMICAL BURN |
1 |
| 164 |
CHEMICAL BURN OF SKIN |
1 |
| 165 |
CHRONIC SPONTANEOUS URTICARIA |
1 |
| 166 |
COLD SWEAT |
1 |
| 167 |
COLD URTICARIA |
1 |
| 168 |
CONTRAINDICATION TO MEDICAL TREATMENT |
1 |
| 169 |
CORNEAL ENDOTHELIITIS |
1 |
| 170 |
COVID-19 IMMUNISATION |
1 |
| 171 |
CRYING |
1 |
| 172 |
CYST |
1 |
| 173 |
CYST RUPTURE |
1 |
| 174 |
DANDRUFF |
1 |
| 175 |
DEHYDRATION |
1 |
| 176 |
DEPRESSED MOOD |
1 |
| 177 |
DERMATITIS ALLERGIC |
1 |
| 178 |
DEVICE LEAKAGE |
1 |
| 179 |
DIABETIC FOOT |
1 |
| 180 |
DISTURBANCE IN ATTENTION |
1 |
| 181 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
| 182 |
DRUG INTOLERANCE |
1 |
| 183 |
DRUG TOLERANCE |
1 |
| 184 |
DYSPEPSIA |
1 |
| 185 |
DYSPHONIA |
1 |
| 186 |
DYSPLASIA |
1 |
| 187 |
DYSPNOEA |
1 |
| 188 |
EMOTIONAL DISORDER |
1 |
| 189 |
ENDOVENOUS ABLATION |
1 |
| 190 |
EOSINOPHILIC CELLULITIS |
1 |
| 191 |
ERECTILE DYSFUNCTION |
1 |
| 192 |
EYE DISCHARGE |
1 |
| 193 |
EYE INFECTION |
1 |
| 194 |
EYE IRRITATION |
1 |
| 195 |
EYE SWELLING |
1 |
| 196 |
FACIAL PAIN |
1 |
| 197 |
FALL |
1 |
| 198 |
FAMILY STRESS |
1 |
| 199 |
FEELING HOT |
1 |
| 200 |
FEELING JITTERY |
1 |
| 201 |
FOETAL HYPOKINESIA |
1 |
| 202 |
GASTRIC PERFORATION |
1 |
| 203 |
GASTROENTERITIS VIRAL |
1 |
| 204 |
GASTROINTESTINAL DISORDER |
1 |
| 205 |
GOUT |
1 |
| 206 |
GOUTY ARTHRITIS |
1 |
| 207 |
HAEMORRHOIDS |
1 |
| 208 |
HERPES ZOSTER |
1 |
| 209 |
HORDEOLUM |
1 |
| 210 |
HOSPITALISATION |
1 |
| 211 |
HYPERHIDROSIS |
1 |
| 212 |
HYPERKERATOSIS |
1 |
| 213 |
HYPERTENSION |
1 |
| 214 |
ILL-DEFINED DISORDER |
1 |
| 215 |
IMPLANT SITE INFECTION |
1 |
| 216 |
INCORRECT DOSE ADMINISTERED |
1 |
| 217 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
| 218 |
INCREASED APPETITE |
1 |
| 219 |
INFECTION |
1 |
| 220 |
INFLUENZA LIKE ILLNESS |
1 |
| 221 |
INJECTION SITE BRUISING |
1 |
| 222 |
INJECTION SITE MASS |
1 |
| 223 |
INJECTION SITE PAPULE |
1 |
| 224 |
INTENTIONAL DOSE OMISSION |
1 |
| 225 |
INTERCEPTED PRODUCT PREPARATION ERROR |
1 |
| 226 |
INTRAUTERINE CONTRACEPTION |
1 |
| 227 |
IRRITABILITY |
1 |
| 228 |
IRRITABLE BOWEL SYNDROME |
1 |
| 229 |
JOINT INJURY |
1 |
| 230 |
LIVER FUNCTION TEST INCREASED |
1 |
| 231 |
LOSS OF CONSCIOUSNESS |
1 |
| 232 |
LOWER LIMB FRACTURE |
1 |
| 233 |
LOWER RESPIRATORY TRACT INFECTION |
1 |
| 234 |
LYMPHOEDEMA |
1 |
| 235 |
MELANOCYTIC NAEVUS |
1 |
| 236 |
METABOLIC DYSFUNCTION-ASSOCIATED LIVER DISEASE |
1 |
| 237 |
MOVEMENT DISORDER |
1 |
| 238 |
MUSCLE SPASMS |
1 |
| 239 |
MUSCULOSKELETAL CHEST PAIN |
1 |
| 240 |
MYOCARDIAL INFARCTION |
1 |
| 241 |
NAIL GROWTH ABNORMAL |
1 |
| 242 |
NASAL CONGESTION |
1 |
| 243 |
NASOPHARYNGITIS |
1 |
| 244 |
NECK PAIN |
1 |
| 245 |
NEEDLE ISSUE |
1 |
| 246 |
NEOPLASM MALIGNANT |
1 |
| 247 |
NERVOUSNESS |
1 |
| 248 |
NEURODERMATITIS |
1 |
| 249 |
NORMAL NEWBORN |
1 |
| 250 |
OROPHARYNGEAL PAIN |
1 |
| 251 |
PAIN IN EXTREMITY |
1 |
| 252 |
PAIN IN JAW |
1 |
| 253 |
PALPITATIONS |
1 |
| 254 |
PARONYCHIA |
1 |
| 255 |
PATIENT DISSATISFACTION WITH TREATMENT |
1 |
| 256 |
PERIORAL DERMATITIS |
1 |
| 257 |
PIGMENTATION DISORDER |
1 |
| 258 |
POLYMYALGIA RHEUMATICA |
1 |
| 259 |
POOR QUALITY SLEEP |
1 |
| 260 |
PROCEDURAL PAIN |
1 |
| 261 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
1 |
| 262 |
PRODUCT ADMINISTRATION INTERRUPTED |
1 |
| 263 |
PRODUCT AVAILABILITY ISSUE |
1 |
| 264 |
PRODUCT DOSE OMISSION |
1 |
| 265 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
1 |
| 266 |
PRODUCT QUALITY ISSUE |
1 |
| 267 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
1 |
| 268 |
PRODUCT USE COMPLAINT |
1 |
| 269 |
PRODUCTIVE COUGH |
1 |
| 270 |
PURPURA |
1 |
| 271 |
RASH MACULAR |
1 |
| 272 |
REBOUND EFFECT |
1 |
| 273 |
RHEUMATOID ARTHRITIS |
1 |
| 274 |
RHINORRHOEA |
1 |
| 275 |
ROAD TRAFFIC ACCIDENT |
1 |
| 276 |
ROSACEA |
1 |
| 277 |
SCRATCH |
1 |
| 278 |
SENSATION OF FOREIGN BODY |
1 |
| 279 |
SENSITIVE SKIN |
1 |
| 280 |
SHOULDER OPERATION |
1 |
| 281 |
SKIN CANCER |
1 |
| 282 |
SKIN DEPIGMENTATION |
1 |
| 283 |
SKIN FISSURES |
1 |
| 284 |
SKIN HAEMORRHAGE |
1 |
| 285 |
SKIN LESION |
1 |
| 286 |
SKIN TIGHTNESS |
1 |
| 287 |
SKIN ULCER |
1 |
| 288 |
SNEEZING |
1 |
| 289 |
SOMNOLENCE |
1 |
| 290 |
SQUAMOUS CELL CARCINOMA OF SKIN |
1 |
| 291 |
STAPHYLOCOCCAL INFECTION |
1 |
| 292 |
SUBCUTANEOUS ABSCESS |
1 |
| 293 |
SURGERY |
1 |
| 294 |
SYMPTOM RECURRENCE |
1 |
| 295 |
THERAPY CESSATION |
1 |
| 296 |
THERMAL BURN |
1 |
| 297 |
THREAT OF REDUNDANCY |
1 |
| 298 |
TINNITUS |
1 |
| 299 |
TOOTH EXTRACTION |
1 |
| 300 |
TOOTH INFECTION |
1 |
| 301 |
ULCER |
1 |
| 302 |
UNEVALUABLE EVENT |
1 |
| 303 |
UPPER LIMB FRACTURE |
1 |
| 304 |
URINARY TRACT INFECTION |
1 |
| 305 |
UTERINE PROLAPSE |
1 |
| 306 |
VISION BLURRED |
1 |
| 307 |
VULVAL CANCER |
1 |
| 308 |
WEIGHT DECREASED |
1 |
| 309 |
WEIGHT INCREASED |
1 |
| 310 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
| 311 |
WOUND |
1 |